MAP, a protein interacting with a tumor suppressor, merlin, through the run domain

Biochemical and Biophysical Research Communications

Volumn 325, Issue 3, 2004, Pages 774-783

  Lee, Il Kyu ^a   Kim, Kyung Soo ^a   Kim, Hongtae ^a   Lee, Joo Yong ^a   Ryu, Chung Hun ^a   Chun, Heung Jae ^a   Lee, Kyoung Uk ^a   Lim, Young ^a   Kim, Young Hoon ^a   Huh, Pil Woo ^a   Lee, Kweon Haeng ^a   Han, Sang Ick ^a   Jun, Tae Youn ^a   Rha, Hyoung Kyun ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Central nervous system; Merlin associated protein; Neurofibromatosis type 2; Src homology 3

Indexed keywords

GUANOSINE TRIPHOSPHATASE; ISOPROTEIN; MERLIN; MICROTUBULE ASSOCIATED PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; MOLECULAR CLONING; MOLECULAR INTERACTION; MOUSE; NONHUMAN; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION; TWO HYBRID SYSTEM; YEAST;

3T3 CELLS; AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; CELL CYCLE PROTEINS; MICE; MOLECULAR SEQUENCE DATA; MOLECULAR WEIGHT; NEUROFIBROMIN 2; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; TUMOR SUPPRESSOR PROTEINS; TWO-HYBRID SYSTEM TECHNIQUES;

FALCO COLUMBARIUS;

EID: 8444251325     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.10.095     Document Type: Article

References (34)

1. R.L. Martuza, and R. Eldridge Neurofibromatosis 2 (bilateral acoustic neurofibromatosis) N. Engl. J. Med. 318 1988 684 688
2. J.F. Gusella, V. Ramesh, M. MacCollin, and L.B. Jacoby Neurofibromatosis 2: loss of merlin's protective spell Curr. Opin. Genet. Dev. 6 1996 87 92
3. G.A. Rouleau, P. Merel, M. Lutchman, M. Sanson, J. Zucman, C. Marineau, K. Hoang-Xuan, S. Demczuk, C. Desmaze, and B. Plougastel Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2 Nature 363 1993 515 521
4. J.A. Trofatter, M.M. MacCollin, J.L. Rutter, J.R. Murrell, M.P. Duyao, D.M. Parry, R. Eldridge, N. Kley, A.G. Menon, and K. Pulaski A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor Cell 72 1993 791 800
5. J.F. Gusella, V. Ramesh, M. MacCollin, and L.B. Jacoby Merlin: the neurofibromatosis 2 tumor suppressor Biochim. Biophys. Acta 1423 1999 M29 M36
6. A.B. Bianchi, T. Hara, V. Ramesh, J. Gao, A.J. Klein-Szanto, F. Morin, A.G. Menon, J.A. Trofatter, J.F. Gusella, and B.R. Seizinger Mutations in transcript isoforms of the neurofibromatosis 2 gene in multiple human tumour types Nat. Genet. 6 1994 185 192
7. A.H. Chishti, A.C. Kim, S.M. Marfatia, M. Lutchman, M. Hanspal, H. Jindal, S.C. Liu, P.S. Low, G.A. Rouleau, N. Mohandas, J.A. Chasis, J.G. Conboy, P. Gascard, Y. Takakuwa, S.C. Huang, E.J. Benz Jr., A. Bretscher, R.G. Fehon, J.F. Gusella, V. Ramesh, F. Solomon, V.T. Marchesi, S. Tsukita, and K.B. Hoover The FERM domain: a unique module involved in the linkage of cytoplasmic proteins to the membrane Trends Biochem. Sci. 23 1998 281 282
8. K. Ikeda, Y. Saeki, C. Gonzalez-Agosti, V. Ramesh, and E.A. Chiocca Inhibition of NF2-negative and NF2-positive primary human meningioma cell proliferation by overexpression of merlin due to vector-mediated gene transfer J. Neurosurg. 91 1999 85 92
9. H. Morrison, L.S. Sherman, J. Legg, F. Banine, C. Isacke, C.A. Haipek, D.H. Gutmann, H. Ponta, and P. Herrlich The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44 Genes Dev. 15 2001 968 980
10. L. Sherman, H.M. Xu, R.T. Geist, S. Saporito-Irwin, N. Howells, H. Ponta, P. Herrlich, and D.H. Gutmann Interdomain binding mediates tumor growth suppression by the NF2 gene product Oncogene 15 1997 2505 2509
11. M. Giovannini, E. Robanus-Maandag, M. van der Valk, M. Niwa-Kawakita, V. Abramowski, L. Goutebroze, J.M. Woodruff, A. Berns, and G. Thomas Conditional biallelic Nf2 mutation in the mouse promotes manifestations of human neurofibromatosis type 2 Genes Dev. 14 2000 1617 1630
12. A.I. McClatchey, I. Saotome, K. Mercer, D. Crowley, J.F. Gusella, R.T. Bronson, and T. Jacks Mice heterozygous for a mutation at the Nf2 tumor suppressor locus develop a range of highly metastatic tumors Genes Dev. 12 1998 1121 1133
13. A. Tikoo, M. Varga, V. Ramesh, J. Gusella, and H. Maruta An anti-Ras function of neurofibromatosis type 2 gene product (NF2/Merlin) J. Biol. Chem. 269 1994 23387 23390
14. J.Y. Lim, H. Kim, Y.H. Kim, S.W. Kim, P.W. Huh, K.H. Lee, S.S. Jeun, H.K. Rha, and J.K. Kang Merlin suppresses the SRE-dependent transcription by inhibiting the activation of Ras-ERK pathway Biochem. Biophys. Res. Commun. 302 2003 238 245
15. H. Kim, J.Y. Lim, Y.H. Kim, S.H. Park, K.H. Lee, H. Han, S.S. Jeun, J.H. Lee, and H.K. Rha Inhibition of ras-mediated activator protein 1 activity and cell growth by merlin Mol. Cells 14 2002 108 114
16. J.Y. Kim, H. Kim, S.S. Jeun, S.J. Rha, Y.H. Kim, Y.J. Ko, J. Won, K.H. Lee, H.K. Rha, and Y.P. Wang Inhibition of NF-kappaB activation by merlin Biochem. Biophys. Res. Commun. 296 2002 1295 1302
17. R.J. Shaw, J.G. Paez, M. Curto, A. Yaktine, W.M. Pruitt, I. Saotome, J.P. O'Bryan, V. Gupta, N. Ratner, C.J. Der, T. Jacks, and A.I. McClatchey The Nf2 tumor suppressor, merlin, functions in Rac-dependent signaling Dev. Cell 1 2001 63 72
18. J.Y. Lee, H. Kim, C.H. Ryu, J.Y. Kim, B.H. Choi, Y. Lim, P.W. Huh, Y.H. Kim, K.H. Lee, T.Y. Jun, H.K. Rha, J.K. Kang, and C.R. Choi Merlin, a tumor suppressor, interacts with transactivation-responsive RNA-binding protein and inhibits its oncogenic activity J. Biol. Chem. 279 2004 30265 30273
19. H. Kim, N.J. Kwak, J.Y. Lee, B.H. Choi, Y. Lim, Y.J. Ko, Y.H. Kim, P.W. Huh, K.H. Lee, H.K. Rha, and Y.P. Wang Merlin neutralizes the inhibitory effect of Mdm2 on p53 J. Biol. Chem. 279 2004 7812 7818
20. M. Sainio, F. Zhao, L. Heiska, O. Turunen, M. den Bakker, E. Zwarthoff, M. Lutchman, G.A. Rouleau, J. Jaaskelainen, A. Vaheri, and O. Carpen Neurofibromatosis 2 tumor suppressor protein colocalizes with ezrin and CD44 and associates with actin-containing cytoskeleton J. Cell Sci. 110 1997 2249 2260
21. A. Murthy, C. Gonzalez-Agosti, E. Cordero, D. Pinney, C. Candia, F. Solomon, J. Gusella, and V. Ramesh NHE-RF, a regulatory cofactor for Na(+)-H+ exchange, is a common interactor for merlin and ERM (MERM) proteins J. Biol. Chem. 273 1998 1273 1276
22. D.R. Scoles, D.P. Huynh, P.A. Morcos, E.R. Coulsell, N.G. Robinson, F. Tamanoi, and S.M. Pulst Neurofibromatosis 2 tumour suppressor schwannomin interacts with betaII-spectrin Nat. Genet. 18 1998 354 359
23. V.J. Obremski, A.M. Hall, and C. Fernandez-Valle Merlin, the neurofibromatosis type 2 gene product, and beta1 integrin associate in isolated and differentiating Schwann cells J. Neurobiol. 37 1998 487 501
24. M. Jannatipour, P. Dion, S. Khan, H. Jindal, X. Fan, J. Laganiere, A.H. Chishti, and G.A. Rouleau Schwannomin isoform-1 interacts with syntenin via PDZ domains J. Biol. Chem. 276 2001 33093 33100 (Epub 2001 Jun 29)
25. D.R. Scoles, D.P. Huynh, M.S. Chen, S.P. Burke, D.H. Gutmann, and S.M. Pulst The neurofibromatosis 2 tumor suppressor protein interacts with hepatocyte growth factor-regulated tyrosine kinase substrate Hum. Mol. Genet. 9 2000 1567 1574
26. D. Gietz, A. St. Jean, R.A. Woods, and R.H. Schiestl Improved method for high efficiency transformation of intact yeast cells Nucleic Acids Res. 20 1992 1425
27. I. Park, J. Chung, C.T. Walsh, Y. Yun, J.L. Strominger, and J. Shin Phosphotyrosine-independent binding of a 62-kDa protein to the src homology 2 (SH2) domain of p56lck and its regulation by phosphorylation of Ser-59 in the lck unique N-terminal region Proc. Natl. Acad. Sci. USA 92 1995 12338 12342
28. M.A. Hoyt, L. Totis, and B.T. Roberts S. cerevisiae genes required for cell cycle arrest in response to loss of microtubule function Cell 66 1991 507 517
29. T. Nakamura, J. Hillova, R. Mariage-Samson, M. Onno, K. Huebner, L.A. Cannizzaro, L. Boghosian-Sell, C.M. Croce, and M. Hill A novel transcriptional unit of the tre oncogene widely expressed in human cancer cells Oncogene 7 1992 733 741
30. C. Fankhauser, J. Marks, A. Reymond, and V. Simanis The S. pombe cdc16 gene is required both for maintenance of p34cdc2 kinase activity and regulation of septum formation: a link between mitosis and cytokinesis? EMBO J. 12 1993 2697 2704
31. C. Fankhauser, and V. Simanis The cdc7 protein kinase is a dosage dependent regulator of septum formation in fission yeast EMBO J. 13 1994 3011 3019
32. U.S. Vogel, R.A. Dixon, M.D. Schaber, R.E. Diehl, M.S. Marshall, E.M. Scolnick, I.S. Sigal, and J.B. Gibbs Cloning of bovine GAP and its interaction with oncogenic ras p21 Nature 335 1988 90 93
33. D.A. Hughes, Y. Fukui, and M. Yamamoto Homologous activators of ras in fission and budding yeast Nature 344 1990 355 357
34. I. Callebaut, J. de Gunzburg, B. Goud, and J.P. Mornon RUN domains: a new family of domains involved in Ras-like GTPase signaling Trends Biochem. Sci. 26 2001 79 83